Allotex’s Post

Introducing MediMax MG, a state-of-the-art device setting a new standard in cell suspension preparation from solid tissue. 🌟 ✔ Automated Precision: Designed for mechanical disaggregation of human tissues, ensuring safe and standardized tissue preparation. ✔ Consistency & Reliability: Eliminates operator variability, enhancing the predictability and success of regenerative therapies. ✔ Essential Innovation: A crucial component of our tissue processing lineup, crafted with a profound understanding of regenerative medicine’s evolving needs. #MediMaxMG #RegenerativeMedicine #HealthcareInnovation #medicine #Medigraft #tissueengineering #innovationinmedicine

Introducing MediMax MG, a state-of-the-art device setting a new standard in cell suspension preparation from solid tissue. 🌟 ✔ Automated Precision: Designed for mechanical disaggregation of human tissues, ensuring safe and standardized tissue preparation. ✔ Consistency & Reliability: Eliminates operator variability, enhancing the predictability and success of regenerative therapies. ✔ Essential Innovation: A crucial component of our tissue processing lineup, crafted with a profound understanding of regenerative medicine’s evolving needs. #MediMaxMG #RegenerativeMedicine #HealthcareInnovation #medicine #Medigraft #tissueengineering #innovationinmedicine

Discover #MediMaxMG—an automated marvel revolutionizing tissue preparation. 🌟 Engineered with precision and tailored for regenerative medicine, it ensures safe, standardized disaggregation of human tissues. 🔬 By eliminating variability, it enhances consistency, paving the way for predictable, successful regenerative therapies. 🧬 #medicine #Medigraft #tissueengineering #innovationinmedicine #medimaxmg

Discover #MediMaxMG—an automated marvel revolutionizing tissue preparation. 🌟 Engineered with precision and tailored for regenerative medicine, it ensures safe, standardized disaggregation of human tissues. 🔬 By eliminating variability, it enhances consistency, paving the way for predictable, successful regenerative therapies. 🧬 #medicine #Medigraft #tissueengineering #innovationinmedicine #medimaxmg

🌟 Elevating Patient Care: MIMOSA Diagnostics Receives $500K to Launch in the U.S. Market! 🇺🇸 MIMOSA Diagnostics Inc. has created a revolutionary handheld tissue imaging device that can detect skin injuries before they’re visible to the naked eye, reducing risks of wounds, infections, amputations, and even death. With a $500,000 boost from ACOA - APECA, MIMOSA is expanding its team and ramping up manufacturing for the U.S. market! 🩺✨ “Our growth is enabling us to bring our product to clinicians who are making a tangible difference,” shared Dr. Karen Cross, CEO. “We’re proud to contribute to a higher standard of care.” #HealthTech #Innovation #MedicalDevices #TissueImaging #PatientCare

👀 Get an insider’s perspective on FORCE REPAIR Wounds from our partner Histocell. Regenerative Medicine! In our latest FORCE REPAIR video, Begoña Castro shares how Histocell. Regenerative Medicine is driving innovation in chronic wound management - supporting the development and manufacturing of advanced medical devices for hard-to-heal wounds. 📍 The video was filmed at last year’s #EWMA conference, presented as we prepare for EWMA 2025 in Barcelona (26–28 March , 2025). 📽️ Watch the full video here: https://lnkd.in/d9tHk4SQ #EWMA2024 #EWMA2025 #FORCEREPAIR #Innovation #HorizonEU

We're proud to announce that Professor Yehuda Ringel will be presenting Alviv Laser Solutions's latest pre-clinical and clinical results at the @FNM conference. 📢 ALVIV LS is 𝗿𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗶𝗻𝗴 𝗙𝗲𝗰𝗮𝗹 𝗜𝗻𝗰𝗼𝗻𝘁𝗶𝗻𝗲𝗻𝗰𝗲 (𝗙𝗜) treatment through our innovative 𝗹𝗮𝘀𝗲𝗿-𝗯𝗮𝘀𝗲𝗱 𝘁𝗵𝗲𝗿𝗮𝗽𝘆. Unlike traditional approaches that focus solely on managing symptoms, our solution directly addresses the underlying cause through a series of quick, painless treatments. ✅ We're excited to share that our 𝗙𝗶𝗿𝘀𝘁-𝗶𝗻-𝗛𝘂𝗺𝗮𝗻 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 𝗶𝘀 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀𝗶𝗻𝗴 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹𝗹𝘆, with promising safety and feasibility outcomes. This marks a significant milestone in our mission to transform FI treatment. #MedicalInnovation #ClinicalTrials #MedTech #Healthcare #FNM2024 #BioTechnology"

"Thrilled to share a significant milestone in my journey: my patent for a reusable bone marrow biopsy device has been officially granted! 🌟 This innovation aims to streamline procedures, reduce waste, environment friendly and ultimately enhance patient care in the realm of healthcare. Grateful for the support of my team and mentors #Dasari Yogeshwar, #Prof Ramjee Repaka, #Ashish Sahani throughout this process. Excited for the impact ahead! Also a special thanks to #VIJAY KUMAR SHARMA for thorough discussion and suggestions. #HealthcareInnovation #PatentGranted #BiomedicalEngineering"

Exciting news from BioStem Technologies (OTC: BSEM) They've received a Notice of Allowance from the USPTO for our patent on sterile human placental allografts. This breakthrough, the first in the fenestrated wound care market, enhances their IP portfolio and supports our innovative BioREtain® process. These allografts are designed to improve wound care by allowing exudate to escape while maintaining surface area. Stay tuned as they continue to lead in regenerative medicine! https://lnkd.in/egPvKsfP 📰 Stay ahead in healthcare by following Practical Patient Care on LinkedIn! Get the latest news and insights on patient care and clinical advancements. Join our community to stay informed and enhance your knowledge. Follow us today! #PracticalPatientCare #Innovation #WoundCare #BioStemTechnologies

Meet Jan Holgersson, VERIGRAFT's Chief Medical Officer, Chairman and Co-Founder. In this short video, Jan shares his vision for transforming personalized medicine with VERIGRAFT’s groundbreaking tissue therapy technology. Discover how his expertise and passion are driving innovation to create life-changing solutions for patients worldwide. Capital Cell #tissuetherapies #gothenburg #personalizedmedicine